Research News - June 26, 2015

MGH Metabolic Imaging Core
Director: Martin Torriani, MD, MSc
55 Fruit Street - YAW 6048, Boston, MA 02129

The MGH Metabolic Imaging Core provides Mass General and Partners investigators with access to non-invasive metabolic imaging. We perform a wide array of imaging modalities including CT, MRI and multi-nuclear MRS, as well as have expertise in image acquisition, processing, display and data analysis. We perform state-of-the-art imaging for body composition analysis (MRS of muscle, liver, marrow and adipose tissue), high-resolution imaging of joints and soft tissues, and biochemical mapping of cartilage (T2, T1rho, T2* mapping).

Learn more by visiting the MGH Metabolic Imaging Core website.

Beginning 6/26/15, the CCM animal orientation and facility access training course will be offered exclusively online via Heathstream. For more information, please click here

As many of you know, we conducted a RAG System Days Survey within the Partners HealthCare organization and hospitals to determine the level of interest within our user community around system updates and projects that relate to our research administrative systems – InfoEd, Insight, Navigator, and MicroStrategy.

Thank you to everyone that participated! Your feedback was appreciated and helped validate holding the RAG System Days. Please click he​re for the Survey results.

RAG System Days (InfoEd, Insight, MicroStrategy)

The RAG System Days will focus on InfoEd, Insight, and MicroStrategy be held on:​

• MGH – Tuesday July 28th @ Haber Auditorium and
• BWH – Monday August 3rd @ Duncan Reid Auditorium

All PHS employees that are interested in attending please click here to sign up.

Research Navigator Q & A
Research Navigator Q & A sessions will be held separately on the following days:​

• MGH – 7/27 10AM-12PM, 1PM-3PM (Haber Auditorium)
• BWH – 7/28 10AM-12PM, 2:30PM-4:30PM (70 Francis Street – Shapiro Boardroom)​
• PHS Central Offices – 7/29 1PM-4PM (Minot Conference Room)

​
​All PHS employees that are interested in attending the Navigator Q & A please click here to sign up.

Wednesday, August 4, 1:30-2:30pm, Simches 3.120

Sponsored by the MGH Clinical Research Program and MGH Office of Research Compliance

Pamela Richtmyer, Associate, MGH Research Compliance, will review the do's and don’ts of research subject remuneration and the policies on payments to human subjects and cash control accountability.

Registration is required. Contact Jillian Tonelli with further questions about this session.

The Executive Committee on Research (ECOR) is accepting applications for the August 1st deadline for the Deliberative Interim Support Funding g.  August is the second of three standing deadlines for these awards in 2015. The next deadline will be December 1, 2015.  

What are they?
Deliberative Interim Support Funding
This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense).  Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).  The Deliberative Interim Support process is open to:

1. Investigators whose grants were not scored or whose scores were not translated into a percentile ranking.
2. Investigators whose grants received scores >20th percentile.
3. Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
4. Investigators who have already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application and are now requesting support for their A1 or A0 resubmission.  Investigators in this category must apply through the Deliberative Interim Support process for their A1 and A0 resubmission regardless of the score they received on their resubmitted grant.

When is the deadline?
Saturday, August 1, 2015 - 5:00 PM

How do I learn more and apply?
Deliberative Interim Support Funding - Click here

The NIH Research Supplements to Promote Diversity in Health-Related Research provide funding to attract underrepresented in medicine (URM) trainees and faculty to research careers

To learn more about this opportunity and to determine your eligibility as a PI or candidate, please review the CDI FAQ sheet about NIH Diversity Supplements. More questions? Please contact cdi@partners.org.

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities.  Note that proposals are still routed through the standard InfoEd/Research Management process.

• Established Investigator Grants, Musculoskeletal Transplant Foundation (MTF)
• W.F. Enneking Career Development Award, Musculoskeletal Transplant Foundation (MTF)
• Career Development Grants, Cerebral Palsy Alliance/Research Foundation
• Research Grant Program, Dravet Syndrome Foundation (DSF)
• Accelerating Drug Discovery for Frontotemporal Degeneration RFP, Alzheimer's Drug Discovery Foundation (ADDF)

Please click here for further details on these funding opportunities.

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

• Name of the Principal Investigator with appropriate contact information
• A descriptive title of the potential application
• Brief description of the project
• Brief description of why you specifically should be selected to receive institutional nomination for this award

In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

• Advancing Health Disparities Interventions through Community-Based Participatory Research (U01) – NEW!
• NIAMS Rheumatic Diseases Research Resource-based Centers (P30)
• Asthma and Allergic Diseases Cooperative Research Centers (U19)
• Career Development Program in Emergency Care Research (K12)
• Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm

MGH ECOR Formulaic Bridge Funding
Application Deadline: July 7, 7th day of each month

Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals

Clinical Research Spotlight Series: Study Coordinator Discussion Group – July 15

Looking for something you saw in a previous Research News release? Check out our archive!